![]({
"default": "https://staging-ddw.ams3.cdn.digitaloceanspaces.com/thumbs/intellispace-genomics_1570527968_1800x1010.png",
"tablet-wide": "https://staging-ddw.ams3.cdn.digitaloceanspaces.com/thumbs/intellispace-genomics_1570527968_1280x720.png",
"tablet-small": "https://staging-ddw.ams3.cdn.digitaloceanspaces.com/thumbs/intellispace-genomics_1570527968_968x544.png",
"phone-wide": "https://staging-ddw.ams3.cdn.digitaloceanspaces.com/thumbs/intellispace-genomics_1570527968_680x.png"
})
With 17 million new cases of cancer worldwide in 2018, the burden of cancer on healthcare systems around the world is undeniable. To manage and care for cancer patients, many disciplines must collaborate accross clinical settings and the number of alternative treatment pathways is increasing.
With the incredible advancements in genome sequencing technology, personalized cancer treatment suggestions are becoming far more accessible. However, sequencing reveals vast amounts of genomic data that needs be converted into actionable information for
